Europe Drug Discovery Market - Size
Base Year For Estimation
2023
Forecast Data Period
2024-2030
Historical Data Period
2018-2021
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
Drug discovery is a process of inventing a new medication in the field of pharmaceuticals, biotechnology, and pharmacology. It is a complex, lengthy and expensive process. Though advanced technologies are available, the success rate of drug discovery is very low and the time involved is relatively high.
Europe Drug Discovery Market Segments Size & Growth:
Europe drug discovery market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Rise in healthcare expenditure, Highly robust and populated pipeline for novel drugs and Improvement in the therapeutic discovery ventures. However, the Market shift from branded to generic drugs and Stringent regulations for drug discovery are thereby hampering the market growth.
Europe Drug Discovery Market Segments Share:
Europe drug discovery market is categorised into
Europe Drug Discovery Market - Growth
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
technology which comprises of QPCR, DNA microarrays, Protein microarrays, High-throughput screening, Mass spectrometry, Gel Electrophoresis, Chromatography, Protein and Nucleic acid isolation, and Others. By service, the market is segmented into Pharmaceutical Services, Drug Metabolism and Pharmacokinetics (DMPK) Services, Pharmaceutical Services, Chemical Services, and Biological Services. By End-users, the market is segmented into Biotech companies, Pharmaceutical companies, Biopharmaceuticals, Research Institutes, and Others. By Geography, UK and Germany are projected to dominate the market with the most significant share and the growth in the Europe economies is mainly attributed because of huge profit margins and growth prospects.
Europe Drug Discovery Market Trends:
- Roche announced that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark.
- Pfizer Inc. announced that the Food and Drug Administration (FDA) approved a New Drug Application to expand the indication for BOSULIF (bosutinib) to include adult patients with newly
You can also purchase parts of this report. Do you want to check out a section wise price list
Europe Drug Discovery Market - Porter's Five Force Analysis
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
diagnosed chronic phase Philadelphia chromosome-positive chronic myelogenous leukaemia (Ph+ CML).
Europe Drug Discovery Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players, such as
- Johnson and Johnson
- AstraZeneca PLC
- Roche Holding AG
- Eli Lily
- Boehringer Ingelheim, INC.
Exclusive Benefits
Credibility and
Transparency
We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.
Exhaustive
Coverage
Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.
Competitive
Edge
Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.
Golden
pportunities
Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.
Top-notch Reportsd
Guaranteed
Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.
Post Purchase
Support
Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.
